Ryvu Therapeutics SA's total assets for Q3 2025 were zł255.34M, a decrease of -9.19% from the previous quarter. PL:RVU total liabilities were zł184.12M for the fiscal quarter, a -0.98% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.